ArticleCancers2021
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models.
Fabien Muselli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancers2021
Fabien Muselli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.